(Q40490649)

21 September 2017

1 reference

title

Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus (English)

1 reference

21 September 2017

2

R N Brogden

1 reference

21 September 2017

K J Palmer

1

1 reference

21 September 2017

publication date

1 July 1993

1 reference

21 September 2017

1 reference

21 September 2017

volume

46

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

92-125

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199346010-00007

21 September 2017

exact match

0 references

cites work

Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.

1 reference

12 December 2020

Evaluation of the efficacy and safety of Diamicron in non-insulin-dependent diabetic patients.

1 reference

12 December 2020

Long-term comparison of oral hypoglycemic agents in diabetic retinopathy. Gliclazide vs. other sulfonylureas.

1 reference

12 December 2020

Serum gliclazide concentration in diabetic patients. Relationship between gliclazide dose and serum concentration.

1 reference

12 December 2020

Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function

1 reference

12 December 2020

Inhibitory action of gliclazide on platelet functions

1 reference

12 December 2020

Effect of gliclazide on prostaglandin and thromboxane synthesis in guinea-pig platelets

1 reference

12 December 2020

Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects.

1 reference

12 December 2020

The effect of Diamicron on the secretion and action of insulin.

1 reference

12 December 2020

Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

1 reference

12 December 2020

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.

1 reference

12 December 2020

Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

[The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)]

1 reference

12 December 2020

The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells

1 reference

12 December 2020

Effect of prolonged gliclazide therapy in non-insulin dependent diabetic subjects.

1 reference

12 December 2020

Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)

1 reference

12 December 2020

The mode of action and clinical pharmacology of gliclazide: a review

1 reference

12 December 2020

Gliclazide in the Treatment of Diabetic Retinopathy

1 reference

12 December 2020

Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide

1 reference

12 December 2020

Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications

1 reference

12 December 2020

The effects of gliclazide on platelet function in patients with diabetes mellitus

1 reference

12 December 2020

Effect of prolonged glyclazide treatment on blood glucose and plasma insulin responses in obese patients with maturity-onset diabetes

1 reference

12 December 2020

Thromboxane/prostacyclin balance in type II diabetes: gliclazide effects.

1 reference

12 December 2020

1 reference

12 December 2020

Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function

1 reference

12 December 2020

Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus

1 reference

12 December 2020

Management of type 2 diabetes mellitus with special reference to metformin therapy.

1 reference

12 December 2020

Lack of weight gain with gliclazide treatment for 30 months in type II diabetes

1 reference

12 December 2020

Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents

1 reference

12 December 2020

Gliclazide alcohol flush

1 reference

12 December 2020

[Clinical trial with a new oral antidiabetic, gliclazid, in general practice (author's transl)]

1 reference

12 December 2020

Influence of gliclazide on glucose-stimulated insulin release in man

1 reference

12 December 2020

Effect of acute administration of gliclazide on the glucose sensitivity of pancreatic B-cells in healthy subjects

1 reference

12 December 2020

Sulphonylureas in vitro do not alter insulin binding or insulin effect on amino acid transport in rat hepatocytes

1 reference

12 December 2020

Changes in glucose disposal and cellular insulin binding in obese black Southern African patients with type 2 diabetes mellitus before and after sulphonylurea therapy

1 reference

12 December 2020

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

1 reference

12 December 2020

Hemobiological activity of gliclazide in diabetes mellitus

1 reference

12 December 2020

Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study

1 reference

12 December 2020

Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes

1 reference

12 December 2020

Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: Clinical assessment

1 reference

12 December 2020

The metabolism of gliclazide in man.

1 reference

12 December 2020

The action of gliclazide on insulin secretion and insulin sensitivity in non-obese non-insulin dependent diabetic patients.

1 reference

12 December 2020

Long term improvement in insulin response with gliclazide treatment

1 reference

12 December 2020

Gliclazide: a general free radical scavenger

1 reference

12 December 2020

Effect of gliclazide on non-insulin dependent diabetes mellitus.

1 reference

12 December 2020

Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs

1 reference

12 December 2020

Influence of blood proteins on biomedical analysis. III. Pharmacokinetics and protein binding of gliclazide

1 reference

12 December 2020

Effects of the combination of insulin and gliclazide compared with insulin alone in type 2 diabetic patients with secondary failure to oral hypoglycemic agents

1 reference

12 December 2020

Gliclazide on long-term therapy increases insulin response to glucose of type II diabetics

1 reference

12 December 2020

Modalities of gliclazide-induced Ca2+ influx into the pancreatic B-cell

1 reference

12 December 2020

The Effect of Sulphonylurea Therapy on Skeletal Muscle Glycogen Synthase Activity and Insulin Secretion in Newly Presenting Type 2 (Non-insulin-dependent) Diabetic Patients

1 reference

12 December 2020

Free radical activity in type 2 diabetes

1 reference

12 December 2020

Home blood glucose monitoring in non-insulin-dependent diabetics: the effect of gliclazide on blood glucose and weight control, a multicentre trial

1 reference

12 December 2020

The physiological action of gliclazide: β-cell function and insulin resistance

1 reference

12 December 2020

Is sulphonylurea therapy effective long term? A 3-year study with gliclazide.

1 reference

12 December 2020

Effect of gliclazide on platelet-activating factor-induced platelet aggregation in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients.

1 reference

12 December 2020

Effect of different stimulators and a blocker of insulin release on islet Na+, K+-ATPase activity

1 reference

12 December 2020

Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation (tolbutamide) to a second generation sulphonylurea (gliclazide).

1 reference

12 December 2020

Anti-platelet effects of long-term treatment with gliclazide in diabetic patients

1 reference

12 December 2020

Combined insulin and sulfonylurea therapy in non-insulin-dependent diabetics with secondary failure to oral drugs: a one year follow-up

1 reference

12 December 2020

Oxygen-derived free radicals in postischemic tissue injury

1 reference

12 December 2020

The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.

1 reference

12 December 2020

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

1 reference

12 December 2020

Insulin and atheroma. 20-yr perspective

1 reference

12 December 2020

Insulin secretion in diabetes mellitus

1 reference

12 December 2020

An evaluation of long-term glycemic control in non-insulin-dependent diabetes mellitus: the relevance of glycated hemoglobin.

1 reference

12 December 2020

Lack of effect of gliclazide on early diabetic nephropathy and retinopathy: a two-year controlled study

1 reference

12 December 2020

Effects of verapamil and nifedipine on gliclazide-induced increase in cytosolic free Ca2+ in pancreatic islet cells.

1 reference

12 December 2020

Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.

1 reference

12 December 2020

The effects of gliclazide in diabetes: a comparison with tolbutamide

1 reference

12 December 2020

No effect of gliclazide on gastric inhibitory polypeptide (GIP) in type II diabetes.

1 reference

12 December 2020

Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus

1 reference

12 December 2020

Safety of fluconazole in women taking oral hypoglycaemic agents

1 reference

12 December 2020

The effect of timing on gliclazide absorption and action

1 reference

12 December 2020

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis

1 reference

12 December 2020

Increased diene conjugates in diabetic subjects with microangiopathy

1 reference

12 December 2020

Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds

1 reference

12 December 2020

Comparison of secondary failure rate between three second generation sulphonylureas

1 reference

12 December 2020

Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia

1 reference

12 December 2020

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

1 reference

12 December 2020

Insulinotropic effects of hypoglycaemic and hyperglycaemic sulphonamides: The ionophoretic hypothesis

1 reference

12 December 2020

[Value of gliclazide in the treatment of early diabetic retinopathy]

1 reference

12 December 2020

Effect of middle-term gliclazide treatment on insulin secretion in non-insulin dependent diabetics

1 reference

12 December 2020

[Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic]

1 reference

12 December 2020

Gliclazide: the effects on lipids in type II diabetes

1 reference

12 December 2020

Direct effect of hypoglycemic sulphonylureas on the cardiovascular system of dogs

1 reference

12 December 2020

Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas

1 reference

12 December 2020

The effects of long term gliclazide administration on insulin secretion and insulin sensitivity

1 reference

12 December 2020

Preventive effect of gliclazide on experimental atherosclerosis in rabbits

1 reference

12 December 2020

Calcium antagonism and calcium entry blockade

1 reference

12 December 2020

Changes in insulin secretion and calcium distribution within B cells induced by gliclazide

1 reference

12 December 2020

Interaction between gliclazide and cimetidine

1 reference

12 December 2020

The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels

1 reference

12 December 2020

An evaluation of the effects of some sulphonylureas on platelet function

1 reference

12 December 2020

Lipid peroxides and atherosclerosis

1 reference

12 December 2020

Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.

1 reference

12 December 2020

Gliclazide (diamicron) in metabolic and vascular treatment of diabetes mellitus

1 reference

12 December 2020

The Achilles heel of the University Group Diabetes Program

1 reference

12 December 2020

Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patients

1 reference

12 December 2020

10.2165/00003495-199346010-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1053052042

0 references

1 reference